5 курс / ОЗИЗО Общественное здоровье и здравоохранение / Стратегия_ВОЗ_в_области_народной_медицины_2002_2005_гг_ВОЗ

Journal of Obstetrics and Gynecology, 1997, 177:1556–1561.

38. Studdert DM et al. Medical malpractice implications of alternative medicine. Journal of the

American Medical Association, 1998, 280:1569–1575.

39. Reported by World Federation of Chiropractic, 2000.

40. Reported by World Federation of Acupuncture-Moxibustion Societies, 2000.

41. World Health Organization. Regulatory Situation of Herbal Medicines. A Worldwide Review.

Geneva, World Health Organization (document reference WHO/TRM/98.1).

42. Norges Offentlige Utredninger [Norway Official Reports]. NOU 1998:21. Ultredning fra et utvalg

oppnevnt av Sosial — og helsedepartementet Avgitt til Sosial — og helsedepartementet [Report

of a committee, appointed by the Ministry of Health and Social Affairs, to the Ministry of Health

and Social Affairs]. Alternativ Medisin [Alternative Medicine]. 1998.

43. Vickers A. Complementary medicine. Recent advances. Clinical review. British Medical Journal,

2000, 321:683–686.

44. Bhattcharya B. M.D. programs in the United States with complementary and alternative

medicine education opportunities: an ongoing listing. Journal of Alternative & Complementary

Medicine, 2000, 6:77–90.

45. National Center for Complementary and Alternative Medicine. Expanding Horizons of

Healthcare. Five-year Strategic Plan 2001–2005. Maryland, National Center for

Complementary and Alternative Medicine, 2000.

46. Council of Europe. Resolution 1206 (1999). A European approach to non-conventional

medicines. (Extract from the Official Gazette of the Council of Europe — November 1999)

(document reference 8435). Parliamentary Assembly. 4 November 1999.

47. World Health Organization. Regional Consultation on Development of Traditional Medicine in

South-East Asia Region, 1999. New Delhi, World Health Organization (document reference

SEA/Trad.Med./80).

48. World Health Organization. Report of the Inter-Regional Workshop on Intellectual Property

Rights in the Context of Traditional Medicine. Bangkok, Thailand, 6–8 December 2000. Geneva,

World Health Organization (document reference WHO/EDM/TRM/2001.1)

49. World Health Organization. General Guidelines for Methodologies on Research and Evaluation

of Traditional Medicine. Geneva, World Health Organization, 2000 (document reference WHO/

EDM/TRM/2000.1).

50. European Commission. COST Action B4: Unconventional Medicine. Final Report of the

Management Committee, 1993–98. Brussels, European Commission, 1998 (document

reference EUR 18420 EN).

51. EsSalud/Organizacio´n Panamericana de Salud. Estudio Costo-Efectividad: Programa Nacional

de Medicina Complementaria. Seguro Social de EsSalud (Study of Cost-Effectiveness: National

Program in Complementary Medicine. Social Security of EsSalud). Lima, EsSalud/

Organizacio´n Panamericana de Salud (Pan American Health Organization), 2000.

52. World Health Organization. Counterfeit and Substandard drugs in Myanmar and Vietnam.

Geneva, World Health Organization, 1999 (document reference WHO/EDM/QSM/99.3).

53. Speech of WHO Director-General Dr Gro Harlem Brundtland at the opening of the Commission

for Macroeconomics and Health, Paris, 8 November 2000. Accessible at: http://www.who.int/

director-general/speeches/2000/20001108_paris.html.

54. Berthold HK, Sudhop MD & Bergmann K. Effect of a garlic oil preparation on serum lipoproteins

Ccskrb

and cholesterol metabolism. Journal of American Medical Association, 1998, 279:1900–1902.